Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 44
  • Start Date: December 15, 2021
Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy in Elderly, Frail Newly Diagnosed Myeloma (MMY2035)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 30
  • Start Date: September 1, 2021
An Open Label, Phase 1 Study Evaluating the Activity of Modular CAR T for mYeloma
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 160
  • Start Date: September 2021
Covid-19 Vaccine Responsiveness in Patients With Multiple Myeloma and Waldenstrom's Macroglobulinemia
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 30
  • Start Date: September 1, 2021
Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 60
  • Start Date: July 31, 2021
Mindfulness Meditation and Sleep Disturbances in Hematopoietic Cell Transplant Patients: Inflammatory Mechanisms
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Other, Drug
  • Participants: 510
  • Start Date: June 1, 2021
Optimizing Prolonged Treatment in Myeloma Using MRD Assessment (OPTIMUM)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 41
  • Start Date: June 1, 2021
A Multisite, Phase II Study of Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone (VICD) Induction in Transplant-Eligible Multiple Myeloma Patients
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 24
  • Start Date: June 1, 2021
Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Early Phase 1
  • Intervention Type: Biological
  • Participants: 18
  • Start Date: June 2021
A Pilot Study of Dendritic Cell DKK1 Vaccine for Patients With Monoclonal Gammopathy and Stable or Smoldering Myeloma
Showing 1-12 of 912